IgG4,l
Biosimilar
Reset all filters

Min CHF:
Max CHF:
  1-22 of 22
Supplier Product name Cat.no. Pack size Price
Anti-CD4 [CE9.1 (Clenoliximab)], Human IgG4 lambda, Purified Ab00450-13.0 Ab00450-13.0-BT 550,00 2'170,00
Rozanolixizumab Biosimilar - Research Grade ICH5051-100MG ICH5051-1MG ICH5051-5MG ICH5051-10MG ICH5051-20MG ICH5051-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Teclistamab Biosimilar - Research Grade ICH5209-50MG ICH5209-100MG ICH5209-1MG ICH5209-5MG ICH5209-10MG ICH5209-20MG 420,00 1'298,00 2'331,00 3'390,00 Inquire Inquire
Anti-OSMR (vixarelimab biosimilar) mAb 12-9163-50 12-9163-100 406,00 470,00
Anti- Clenoliximab (CD4) 591757-100uG 882,00
Anti- Garadacimab (F12) 591885-100uG 882,00
Anti- Narsoplimab (MASP2) 592034-100uG 882,00
Anti- Sugemalimab 592214-100uG 882,00
Anti- Tamrintamab (DPEP3) 592230-100uG 882,00
Anti- Tralokinumab (IL13) 592274-100uG 882,00
  1-22 of 22

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch

Business Hours
Monday to Friday
08:00 – 12:00
13:00 – 17:00

Technical Support
tech@lucerna-chem.ch
Business Development
business.dev@lucerna-chem.ch

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern

© Copyright 2021 Lucerna-Chem AG, Switzerland

Order Conditions | Privacy Policy | Terms & Conditions | Impressum